Tetraphase Pharmaceutical

(NASDAQ: TTPH)
Healthcare  |  Biotechnology
0.42 -0.0063 -1.47%
Stock Price | July 15, 2019, 3:59 p.m.
0 Followers
Bid: 0.0
Ask: 0.0
Prev. Close: 0.43
52 Week Low: 0.4122
52 Week High: 3.7676
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Tetraphase Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It creates novel antibiotics for serious and life-threatening multidrug-resistant infections. Its pipeline products are ERAVACYCLINE, TP-271, and TP-6076.

Read more Read less

Recently Viewed Tickers

Premium Stock Watchlist 10/29/2015

3 years ago

Premium Stock Watchlist 10/28/2015

3 years ago
4 years ago
4 years ago

Premium Daily Trade Recommendations | WEN - MOH

4 years ago
4 years ago